Atlas Trials

Karo Bio AB

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Karo Bio AB

RecordFirmDate
Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care (NCT01410383)Karo Bio AB2011-10-01
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe (NCT00677248)Karo Bio AB2008-04-01
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin (NCT00593047)Karo Bio AB2007-11-01
Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia (NCT00776321)Karo Bio AB2006-09-01

Track Karo Bio AB automatically

Every clearance here is in the API, with alerts when new ones post.